InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
Subscribe Login/Register
S&P 500
5,477.90
(
0.16%
)
US TECH 100
19,160.00
(
-0.08%
)
Dow Jones
39,127.80
(
0.04%
)
Brent Oil
84.47
(
0.34%
)
Bitcoin
60,972.72
(
-1.35%
)
Post# of 80490
Next 10
Reply Private New
Public Reply Private Reply New Post
Keep Last Read
Keep Next 10 Report Keyboard Shortcuts
Next 10 Prev Next

rumrunner528

Send PM Follow Ignore
Followers 10
Posts 623
Boards Moderated 0
Alias Born 09/12/2010

rumrunner528

Re: micanwait post# 50673

Wednesday, 07/02/2014 11:39:48 AM

Wednesday, July 02, 2014 11:39:48 AM

Post# of 80490
Mican, in reading the article, I found this curious:

"Roche has earned a reputation as a disciplined acquirer, prepared to walk away from potential deals rather than overpay."

"Chief Executive Severin Schwan abandoned a $6.8 billion deal to buy U.S gene sequencing company Illumina in 2012"

Current market cap of ILMN is over $23 billion. I have thought of a reputation to label Roche with, but it may get my post deleted. I will abandon my plans to acquire any shares of Roche.

Rum
Public Reply Private Reply New Post
Keep Last Read
Keep Last Read Next 10 Report Keyboard Shortcuts
Next 10 Prev Next

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.

Sign Up